The mortality rate of endometrial cancer is relatively high. Endometrial cancer is the second most common gynecological malignant tumor disease after cervical cancer, and it can be divided into estrogen-dependent endometrial cancer and non-estrogen-dependent endometrial cancer, among which the development of estrogen-dependent endometrial cancer is mainly caused by the lack of progesterone to fight against the endometrial proliferation for a long period of time, whereas the pathogenesis of non-estrogen-dependent endometrial cancer is not yet clear. According to the “Endometrial Cancer Diagnosis and Treatment Guidelines” 2022 edition, the mortality rate of endometrial cancer in China was about 23.2% in 2015, so the mortality rate of this malignant disease is relatively high, and women need to be deeply aware of its danger. Women are advised to have regular medical checkups and do relevant screening work, and once abnormal endometrial lesions are detected, they should pay attention to actively cooperate with doctors for intervention and treatment.